Growth Metrics

Vanda Pharmaceuticals (VNDA) Cash from Operations (2016 - 2025)

Vanda Pharmaceuticals' Cash from Operations history spans 16 years, with the latest figure at 29417000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 1518.99% to 29417000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 109442000.0, a 594.56% decrease, with the full-year FY2025 number at 109442000.0, down 594.56% from a year prior.
  • Cash from Operations hit 29417000.0 in Q4 2025 for Vanda Pharmaceuticals, up from 31626000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for VNDA hit a ceiling of 31803000.0 in Q1 2023 and a floor of 33147000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 810000.0 across 5 years, with a median of 1114500.0 in 2022.
  • Biggest five-year swings in Cash from Operations: surged 1113.56% in 2021 and later plummeted 1518.99% in 2025.
  • Tracing VNDA's Cash from Operations over 5 years: stood at 26607000.0 in 2021, then crashed by 64.61% to 9416000.0 in 2022, then crashed by 139.63% to 3732000.0 in 2023, then soared by 51.31% to 1817000.0 in 2024, then plummeted by 1518.99% to 29417000.0 in 2025.
  • Business Quant data shows Cash from Operations for VNDA at 29417000.0 in Q4 2025, 31626000.0 in Q3 2025, and 15252000.0 in Q2 2025.